Hasil Pencarian - Jaeho Jung

  • Menampilkan 1 - 9 hasil dari 9
Perbaiki Hasil
  1. 1
    Hydraulic performance and flow resistance tests of various hydraulic parts for optimal design of a reactor coolant pump for a small modular reactor

    Hydraulic performance and flow resistance tests of various hydraulic parts for optimal design of a reactor coolant pump for a small modular reactor oleh Byeonggeon Bae, Jaeho Jung, Je Yong Yu

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    702 TJ-CD4B (ABL111), a Claudin18.2-targeted 4-1BB tumor engager induces potent tumor-dependent immune response without dose-limiting toxicity in preclinical studies

    702 TJ-CD4B (ABL111), a Claudin18.2-targeted 4-1BB tumor engager induces potent tumor-dependent immune response without dose-limiting toxicity in preclinical studies oleh Wenqing Jiang, Zhengyi Wang, Jaeho Jung, Zhen Sheng, Taylor Guo

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Online Calibration for LTE-Based Antenna Array System

    Online Calibration for LTE-Based Antenna Array System oleh Kyunghoon Kim, Hyunwook Yang, Jaehyun Jang, Tiefeng Sun, Seungwon Choi, Jaeho Jung

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Functional interface layer for a high-performance self-rectifying memristive device using hafnium-zirconia thin film

    Functional interface layer for a high-performance self-rectifying memristive device using hafnium-zirconia thin film oleh Se Yeon Jeong, Jaeho Jung, Hyun Kyu Seo, Jae-Seung Jeong, June Hyuk Lee, Gun Hwan Kim, Min Kyu Yang

    Diterbitkan 2024-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    792 Givastomig, a novel Claudin18.2/4–1BB bispecific antibody, exerts bystander tumor-killing and synergistic anti-tumor activity with therapeutics in 1L/2L treatment for gastric cancer

    792 Givastomig, a novel Claudin18.2/4–1BB bispecific antibody, exerts bystander tumor-killing and synergistic anti-tumor activity with therapeutics in 1L/2L treatment for gastric c... oleh Ke Xu, Zhengyi Wang, Jaeho Jung, Xuejun Liu, Jie Xia, Ao Li, Andrew Zhu, Jane Meng, Chenyu Pan, Zhenhu Li

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    845 ABL503 (TJ-L14B), PD-L1×4–1BB bispecific antibody, reinvigorates exhausted tumor-infiltrating CD8+ T cells and synergizes with PD-1 blockade

    845 ABL503 (TJ-L14B), PD-L1×4–1BB bispecific antibody, reinvigorates exhausted tumor-infiltrating CD8+ T cells and synergizes with PD-1 blockade oleh Seung Hyuck Jeon, Su-Hyung Park, Jaeho Jung, Xuejun Liu, Hyunjoo Kim, Jaehyoung Jeon, Youngkwang Kim, Gihoon You, Kyungjin Park, Claire Xu

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    892 ABL503 (TJ-L14B), PD-L1x4–1BB bispecific antibody induces superior anti-tumor activity by PD-L1-dependent 4–1BB activation with the increase of 4–1BB+CD8+ T cells in tumor microenvironment

    892 ABL503 (TJ-L14B), PD-L1x4–1BB bispecific antibody induces superior anti-tumor activity by PD-L1-dependent 4–1BB activation with the increase of 4–1BB+CD8+ T cells in tumor micr... oleh Wenqing Jiang, Zhengyi Wang, Jaeho Jung, Hyunjoo Kim, Eunsil Sung, Jaehyoung Jeon, Youngkwang Kim, Shinai Lee, Yangmi Lim, Jonghwa Won, Uijung Jung, Hyung-Seung Jin, Gihoon You

    Diterbitkan 2021-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation

    CLDN18.2 and 4-1BB bispecific antibody givastomig exerts antitumor activity through CLDN18.2-expressing tumor-directed T-cell activation oleh Xi Chen, Lin Shen, Cheng Zhang, Jing Gao, Wenqing Jiang, Zhengyi Wang, Jaeho Jung, Chan Chen, Xuejun Liu, Yanni Zhang, Eunsil Sung, Zhen Sheng, Zhen Meng, Yanling Niu, Chanjuan Liu, Keren Jia, Haiyan Liao, Hyejin Chung, Jingwu Z. Zhang, Andrew X. Zhu

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade

    Novel anti-4-1BB×PD-L1 bispecific antibody augments anti-tumor immunity through tumor-directed T-cell activation and checkpoint blockade oleh Lei Fang, Wenqing Jiang, Zhengyi Wang, Su-Hyung Park, Eui-Cheol Shin, Minwoo Jeon, Jaeho Jung, Hyunjoo Kim, Hyung-Don Kim, Shin Hwang, Seongju Jeong, Eunyoung Park, Eunsil Sung, Jaehyoung Jeon, Youngkwang Kim, Ui-jung Jung, Yong-Gyu Son, Youngeun Hong, Hanbyul Lee, Shinai Lee, Yangmi Lim, Jonghwa Won

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: